Test ID: COMTO
Catechol-O-Methyltransferase (COMT) Genotype, Saliva
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Early identification of patients who may show cognitive improvement with treatment for schizophrenia; this is associated with the *2/*2 genotype
Investigation of inhibitor dosing for decreasing L-dopa metabolism
Research use for assessing estrogen metabolism
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) with Allele-Specific Primer Extension (ASPE)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
COMT Genotype, Saliva
Aliases Lists additional common names for a test, as an aid in searching
Catechol O-methyltransferase
External
link
PDF
document
Excel
document
Word
document